PNPLA3 and metabolic dysfunction-associated steatotic liver disease: TM6SF2 and PNPLA3 are two important genes that were identified as conferring susceptibility to NAFLD in a genome-wide association study and an exome-wide association study of multiethnic, population-based cohorts [6, 9].